Drugs on trial

Case
Peter, a 65-year-old man, was diagnosed with localised prostate cancer five years ago (PSA 30, Gleason Score 8, T3b disease) and initially treated with radiotherapy plus a short-term leuprorelin depot regimen.

# Tags